ArticleOncology letters2020

Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib.

Martin Svaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.